Our Team





Principal Investigators

Technology Platform Leaders

  • Monthira Suntiparpluacha, PhD

    Organoid Bank and Profiling

    Postdoctoral Fellow

    PhD (Biotechnology)

    Email: monthira.sun@mahidol.edu

    We have extensive experiences in culturing patient-derived in vitro models (both 2D and 3D cell culture). Our main focus is creating a live biobank of patient-derived organoids from cancer patients and performing drug screening in the 3D platform for personalized drug selection and drug development.

  • Amphun Chaiboonchoe, PhD

    Bioinformatics Analysis

    Research Scientist

    PhD (Computational Systems Biology)

    Email: amphun.cha@mahidol.edu

    My research primarily centers around systems medicine and the intricate interplay between phenotype and genotype. Furthermore, I am interested in integrating 'omics' data with clinical data to identify biomarkers and classify subtypes in several cancers, such as colorectal cancer, using machine learning and deep learning techniques.

  • Romgase Sakamula, PhD

    Multiplex Tissue Imaging

    Postdoctoral Fellow

    PhD (Zoology)

    Email: romgase.sak@mahidol.edu

    As a multiplex imaging researcher in cancer, my focus is unraveling intricate cellular interactions within the tumor microenvironment. By deciphering these complexities, I strive to predict treatment responses, cancer progression, and advance broader medical knowledge, holding promise for improved outcomes in cancer patients and beyond.

Staff Scientists

  • Tongchai Payungwong, PhD

    Postdoctoral Fellow

    PhD (Medicine)

    I am interested in molecular biology and epigenetics in cancer. I working on 2 projects relating to synthetic lethality, biomarker discovery, and drug treatment in cancer. First, The Enhancement of Cell Cycle Inhibitors in Cholangiocarcinoma with epigenetic drug. Second, The Mechanism of recurrent oral cancer.

  • Supawan Jamnongsong

    High-content Imaging Specialist

    MSc (Plant Science)

    My research has focused on System-based profiling in Asian cholangiocarcinoma. I successfully identified the best therapeutics and developed gene expression-based prognosis/predictive markers for cholangiocarcinoma subtype1 (CCA1). I am currently working on finding new treatment strategies to overcome resistance in the CCA1 subtype. I have also worked on the spatial biology of cholangiocarcinoma.

  • Juthamas Sitthikornpaiboon

    Primary Cell Culture Specialist

    MSc (Genetics)

    My project is to create patient-derived models of gynecological cancer for precision medicine studies and clinical use. I also focus on optimizing platforms, i.e. Comet assay and BH3 profiling, for predicting responses to standard and other promising targeted treatments in gynecological cancer patients.

  • Pimkanya More-krong

    Organoid and Cell Imaging Specialist

    MSc (Medical biochemistry)

    We are creating both 2D and 3D cell culture models that can be stored as live biobanks and are useful for identifying new effective cancer-targeting drugs or personalized drug prediction. Besides from establishing the models, I also use multiplex IF staining to perform morphological and phenotype signature evaluation and biomarker study to further support the relevance of these models.

  • Sunisa Prasopporn

    Animal Model Laboratory Specialist

    MSc (Pharmacology)

    My research focused on exploring an acquired vulnerability of drug-resistant cholangiocarcinoma (CCA). Previous work discovered the combination of chemotherapy (GEM/CIS) plus anti-IAP drugs for overcoming drug resistance in CCA. Currently, I am working on ARID1A loss of function mutation by using CRISPR/Cas9 knockout to identify a new drug target for ARID1A mutated CCA.

  • Chanettee Jamyuang

    Reversed Phase Protein Array Specialist

    MSc (Biotechnology)

    As a Reversed Phase Protein Array Specialist, I explore proteomic profiles in cancer, concentrating on drug discovery and understanding drug resistance mechanisms. Committed to advancing treatment strategies through comprehensive proteomic analysis to develop targeted treatment strategies for enhanced therapeutic outcomes.

  • Jantappapa Chanthercrob

    Data Analyst

    MEng (Biomedical Engineering)

    As an oncology data analyst, my main focus is utilizing machine learning to identify cancer subtypes among Thai populations through gene expression profiles. Additionally, I provide proficient bioinformatic frameworks for proteomic data integration and analysis to support our scientists and specialists.

  • Phetthinee Muanjumpon

    Immunohistochemistry Specialist

    MSc (Anatomy)

    I am interested in oxidative stress and antioxidants in skin aging models, both in vitro and in vivo. The interesting proteins and genes in mitochondrial energetics and redox signaling pathways were explored by using biomolecular techniques including mito stress test assay, ROS detection assay, immunofluorescence, and imaging.

  • Tanyapohn Soingam

    MSc (Microbiology)

    The current work is the study on the role of the epidermal microenvironment in the regulation of candidate proteins-modulated photoaging in dermal fibroblasts, the effects of PM 2.5 on mitochondria, and PM 2.5 regulates inflammation and apoptosis by cell culture and molecular technique. My next plan study herbs for cosmetic application.

  • Mutita Pluempreecha

    MSc (immunology)

    To do the research that studies of correlation of HIF-1 and vitamin D receptor in PM2.5 treated lung epithelial cells, I help with this research in part of RNA extraction, real-time PCR, immunofluorescence assay, and other parts. In the future, the study of Nrf2 and Vitamin D receptors. My responsibility is part of the ChlP assay.

  • Sarun Tulakarnwong

    MSc (Bioengineering)

    My research experience includes cell cycle analysis via Edu staining, High-content imaging, in vitro viral assay, inhibitor screening for a viral disease, molecular cloning, viral RNA extraction, and Sequencing data analysis. My current work focuses on dengue viral RNA extraction and viral mutagenesis which contribute to severe disease.

  • Khin Su Su Htwe

    Researcher in Cancer Immunotherapy

    BSc (Pharmacy)

    Our research focuses on the restoration of immune effector cells’ anti-tumor properties from their dysfunctionality state after exposure to cancer cells by small drug compounds using the cancer-immune co-culture system with time-lapse imaging.

  • Apisit Laopiem

    Animal Laboratory Staff

    BSc (Animal Science)

    Assisting with the animal experimentation section of researchers' work involves controlling animal breeding, conducting experiments with the animals, and collecting samples from them for testing purposes.

  • Thanaphon Likhityungyuen

    Multiplex Tissue Imaging Staff

    BSc (Biology)

    My work is responsible for cancer diagnostics using multiplex tissue imaging, especially the t-CyCIF (tissue-based cyclic immunofluorescence) technique that generates multiplexed images of formalin-fixed, paraffin-embedded (FFPE) samples, and participating in research on biomarker development for predicting cancer prognosis and therapeutic response using archival specimens.

  • Pasith Prayoonrat

    Data analyst

    MSc (Computational Biology)

    As a bioinformatics data analyst, I specialize in classifying and subtyping cancer among Thai patients using gene expression profiles while developing a web application platform for aggregating potential cancer subtyping models to assist researchers and clinicians. Additionally, I support the development of analytical pipelines for other projects within the SiSP lab.

Admin and Support Team

This center will never function properly without them

Pisarnsri Krataithong

Programme Coordinator

Students

  • Kodcharat Cheevapruk

    PhD Student

    Systematic analysis of tumor-stroma interaction and its influence on drug sensitivity in multiple myeloma

  • Satinee Aroonpruksakul

    PhD Student

    Drug resistance, acquired Vulnerability, HER2 expression in CCA

  • Oranit Boonphang

    PhD Student

    Identification of Acquired Vulnerabilities in Targeted Therapy Resistant Cholangiocarcinoma

  • Sutthipun suriya

    PhD Student

    Single-cell transcriptional landscape of ovarian cancer dormancy induced by PARP inhibitors and prevention strategies

  • Diana

    PhD Student

    Immunophenotypic differences of TAM subsets between primary and metastasis of Thai UPS and MFS for prognosis

  • Hay Mar Oo

    PhD Student

    Investigation of tumor microenvironment features in Thai pancreatic cancer patients for better patient stratification

  • Krittiyabhorn Kongtanawanich

    PhD Student

    Study of Cholangiocarcinoma Stem Cells

  • Abdifetah Ibrahim Omar

    PhD Student

    Investigating the mechanism of drug tolerant persister cells in the development of therapeutic resistance in Cholangiocarcinoma

  • Tooba Jawwad

    PhD Student

    Exploring the single-cell dynamics of FOXM1 under cell cycle perturbations

  • Melanie Lim

    PhD student

    Development of first-generation dengue RNA vector for cancer immunotherapy

  • Chuttikran Ronsiri

    PhD student

    The effect of anthocyanin in atherosclerotic plaque and its function in C57BL/6 high fat diet induced mice model

  • Kannika Nola

    Ms Student

    The Role of Mitochondria Function in UVB- Impaired Migration of Human Keratinocyte Cells (HaCaT)

  • Punyapa Laprattanawiboon

    Ms Student

    The identification of protein involved in the role of PM2.5-mediated wound healing of mouse skin